Our website content is currently being
updated to reflect our recent transactions.
Sorrento Therapeutics
Home » About » Team » Management


Dr. Henry Ji

Director, President and CEO

Dr Henry Ji

Henry Ji, Ph.D. co-founded and has served as a director of Sorrento Therapeutics, Inc. since January 2006, and as its Chief Executive Officer and President since September 2012. Dr. Ji has more than 18 years of biotechnology and biopharmaceutical experience.

Amar Singh

Senior Vice President, Chief Business Officer

Amar Singh
Mr. Singh , joined Sorrento in January 2014 from Synta Pharmaceuticals, where he most recently served as SVP and Chief Business Officer.

Dr. Vuong Trieu

Director and Chief Scientific Officer

Vuong Trieu, Ph.D., has been involved in drug discovery and development for over 20 years, including his contributions as co-inventor of Abraxane®.

George Uy

Chief Commercial Officer

George Uy has been responsible for the planning and launch of several successful drugs over the past 30 years.

Richard G. Vincent

Executive Vice President and CFO


Richard G. Vincent has served as our Chief Financial Officer since February 2010.  Mr. Vincent brings over 20 years of experience serving as Chief Financial Officer for privately-held and publicly-traded companies in the pharmaceutical and biopharmaceutical industries as well as serving in the public accounting industry for over nine years.


Back to Top »